Medicis, Teva Resolve Solodyn Patent Suit
By Nick Brown · February 28, 2011, 8:20 PM EST
Medicis Pharmaceutical Corp. on Monday resolved its claims in a Maryland federal court that Teva Pharmaceutical USA Inc. infringed two patents through a generic version of acne drug Solodyn....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login